Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls
Neurodegeneration precedes the onset of dementias such as Alzheimer's by several years.
Recent advances in volumetric imaging allow quantification of subtle neuroanatomical …
Recent advances in volumetric imaging allow quantification of subtle neuroanatomical …
Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging
H Rusinek, S De Santi, D Frid, WH Tsui, CY Tarshish… - Radiology, 2003 - pubs.rsna.org
PURPOSE: To determine if medial temporal lobe (MTL) atrophy rate, assessed by using an
automated procedure over the initial time interval of a 6-year, three-time-point longitudinal …
automated procedure over the initial time interval of a 6-year, three-time-point longitudinal …
The posterior parahippocampal gyrus is preferentially affected in age-related memory decline
S Burgmans, MPJ Van Boxtel, KEM Van Den Berg… - Neurobiology of …, 2011 - Elsevier
Atrophy in the medial temporal lobe is generally considered to be highly associated with age-
related memory decline. Volume loss in the hippocampus and entorhinal cortex has …
related memory decline. Volume loss in the hippocampus and entorhinal cortex has …
[HTML][HTML] Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease
A Convit, MJ De Leon, C Tarshish, S De Santi… - Neurobiology of …, 1997 - Elsevier
Our goal was to ascertain the involvement of the temporal lobe in the preclinical (not yet
diagnosable) stages of dementia of the Alzheimer's type (DAT) by using MRI-derived …
diagnosable) stages of dementia of the Alzheimer's type (DAT) by using MRI-derived …
One-year brain atrophy evident in healthy aging
AM Fjell, KB Walhovd… - Journal of …, 2009 - Soc Neuroscience
An accurate description of changes in the brain in healthy aging is needed to understand the
basis of age-related changes in cognitive function. Cross-sectional magnetic resonance …
basis of age-related changes in cognitive function. Cross-sectional magnetic resonance …
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
CR Jack Jr, RC Petersen, YC Xu, SC Waring… - Neurology, 1997 - AAN Enterprises
Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal
lobe (MTL) structures can discriminate between normal elderly control subjects and patients …
lobe (MTL) structures can discriminate between normal elderly control subjects and patients …
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
M Tondelli, GK Wilcock, P Nichelli, CA De Jager… - Neurobiology of …, 2012 - Elsevier
Structural brain changes have been described in both mild cognitive impairment (MCI) and
Alzheimer's disease (AD). However, less is known about whether structural changes are …
Alzheimer's disease (AD). However, less is known about whether structural changes are …
[HTML][HTML] Medial temporal lobe subregional atrophy in aging and Alzheimer's disease: a longitudinal study
L Chauveau, E Kuhn, C Palix, F Felisatti… - Frontiers in aging …, 2021 - frontiersin.org
Medial temporal lobe (MTL) atrophy is a key feature of Alzheimer's disease (AD) but also
occurs in typical aging. To enhance the clinical utility of this biomarker, we need to better …
occurs in typical aging. To enhance the clinical utility of this biomarker, we need to better …
A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging
RI Scahill, C Frost, R Jenkins, JL Whitwell… - Archives of …, 2003 - jamanetwork.com
Objective To investigate the effect of age on global and regional brain volumes and rates of
atrophy, and to compare directly results based on cross-sectional and longitudinal data …
atrophy, and to compare directly results based on cross-sectional and longitudinal data …
Mapping ventricular expansion onto cortical gray matter in older adults
Dynamic changes in the brain's lateral ventricles on magnetic resonance imaging are
powerful biomarkers of disease progression in mild cognitive impairment (MCI) and …
powerful biomarkers of disease progression in mild cognitive impairment (MCI) and …